SCHEMBL24313952

SCHEMBL24313952

O=C(N[S+]([O-])c1ccccc1-c1ccccc1)c1cc2ccc(-c3ccc(F)cc3)cc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HSD11B1 P28845 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC1 Q13547 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ADCY8 P40145 2/20 0.38
ADCY1 Q08828 2/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
ASAH1 Q13510 4/20 0.38
MMP2 P08253 1/20 0.37
POLB P06746 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314214 0.89 NPC1 (0.42) NPC1RAB9AHSD11B1ALDH1A1MAPT
SCHEMBL24313721 0.85 PIM1 (0.49) KMT2AALDH1A1MAPTL3MBTL1MAPK1
SCHEMBL22601061 0.85 CHRNA7 (0.40) NPC1RAB9AALDH1A1TSHRMIF
SCHEMBL22601033 0.85 NPC1 (0.51) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24313789 0.84 NPC1 (0.43) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL22600839 0.84 RAB9A (0.41) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24314307 0.84 RAB9A (0.45) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24313970 0.84 ALDH1A1 (0.40) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL22601146 0.82 NPC1 (0.39) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24314221 0.82 DRD3 (0.36) NPC1RAB9AALDH1A1TSHRMIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed